IE63418B1 - Progression risk of HIV by assay of dehydroepiandrosterone in body fluid - Google Patents
Progression risk of HIV by assay of dehydroepiandrosterone in body fluidInfo
- Publication number
- IE63418B1 IE63418B1 IE326690A IE326690A IE63418B1 IE 63418 B1 IE63418 B1 IE 63418B1 IE 326690 A IE326690 A IE 326690A IE 326690 A IE326690 A IE 326690A IE 63418 B1 IE63418 B1 IE 63418B1
- Authority
- IE
- Ireland
- Prior art keywords
- dhea
- body fluid
- amount
- sample
- hiv
- Prior art date
Links
- FMGSKLZLMKYGDP-USOAJAOKSA-N dehydroepiandrosterone Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CC=C21 FMGSKLZLMKYGDP-USOAJAOKSA-N 0.000 title claims abstract description 73
- 210000001124 body fluid Anatomy 0.000 title claims description 16
- 239000010839 body fluid Substances 0.000 title claims description 16
- FMGSKLZLMKYGDP-UHFFFAOYSA-N Dehydroepiandrosterone Natural products C1C(O)CCC2(C)C3CCC(C)(C(CC4)=O)C4C3CC=C21 FMGSKLZLMKYGDP-UHFFFAOYSA-N 0.000 title description 48
- 229960002847 prasterone Drugs 0.000 title description 48
- 238000003556 assay Methods 0.000 title description 8
- 238000000034 method Methods 0.000 claims abstract description 31
- 208000031886 HIV Infections Diseases 0.000 claims abstract description 13
- 208000037357 HIV infectious disease Diseases 0.000 claims abstract description 12
- 208000033519 human immunodeficiency virus infectious disease Diseases 0.000 claims abstract description 12
- 230000028327 secretion Effects 0.000 claims abstract description 9
- 150000003839 salts Chemical class 0.000 claims abstract description 4
- 238000003018 immunoassay Methods 0.000 claims description 11
- 210000002966 serum Anatomy 0.000 claims description 8
- 210000004369 blood Anatomy 0.000 claims description 6
- 239000008280 blood Substances 0.000 claims description 6
- 102000004190 Enzymes Human genes 0.000 claims description 5
- 108090000790 Enzymes Proteins 0.000 claims description 5
- 210000004027 cell Anatomy 0.000 claims description 5
- 238000001030 gas--liquid chromatography Methods 0.000 claims description 5
- 230000000984 immunochemical effect Effects 0.000 claims description 5
- 210000004698 lymphocyte Anatomy 0.000 claims description 4
- 238000003127 radioimmunoassay Methods 0.000 claims description 4
- 108060003951 Immunoglobulin Proteins 0.000 claims description 3
- 239000000427 antigen Substances 0.000 claims description 3
- 102000036639 antigens Human genes 0.000 claims description 3
- 108091007433 antigens Proteins 0.000 claims description 3
- 230000002255 enzymatic effect Effects 0.000 claims description 3
- 102000018358 immunoglobulin Human genes 0.000 claims description 3
- 238000012360 testing method Methods 0.000 claims description 3
- 238000001262 western blot Methods 0.000 claims description 2
- 208000024891 symptom Diseases 0.000 abstract 1
- 208000030507 AIDS Diseases 0.000 description 14
- 239000000523 sample Substances 0.000 description 11
- 241000725303 Human immunodeficiency virus Species 0.000 description 10
- 102000003992 Peroxidases Human genes 0.000 description 7
- 108040007629 peroxidase activity proteins Proteins 0.000 description 7
- 239000011324 bead Substances 0.000 description 5
- 238000005534 hematocrit Methods 0.000 description 5
- 208000035473 Communicable disease Diseases 0.000 description 3
- 229960002685 biotin Drugs 0.000 description 3
- 239000011616 biotin Substances 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- CZWCKYRVOZZJNM-USOAJAOKSA-N dehydroepiandrosterone sulfate Chemical compound C1[C@@H](OS(O)(=O)=O)CC[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CC=C21 CZWCKYRVOZZJNM-USOAJAOKSA-N 0.000 description 3
- 230000000652 homosexual effect Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 238000005497 microtitration Methods 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 229950009829 prasterone sulfate Drugs 0.000 description 3
- 208000010648 susceptibility to HIV infection Diseases 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- 206010001513 AIDS related complex Diseases 0.000 description 2
- 206010061818 Disease progression Diseases 0.000 description 2
- 108010027044 HIV Core Protein p24 Proteins 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 210000004970 cd4 cell Anatomy 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 238000002405 diagnostic procedure Methods 0.000 description 2
- -1 dipsticks Substances 0.000 description 2
- 230000005750 disease progression Effects 0.000 description 2
- 238000001952 enzyme assay Methods 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 108090001008 Avidin Proteins 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 1
- 102000008394 Immunoglobulin Fragments Human genes 0.000 description 1
- 108010021625 Immunoglobulin Fragments Proteins 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 206010038997 Retroviral infections Diseases 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000003149 assay kit Methods 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000005184 men's health Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000000159 protein binding assay Methods 0.000 description 1
- 238000012205 qualitative assay Methods 0.000 description 1
- 238000012206 semi-quantitative assay Methods 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 229910021653 sulphate ion Inorganic materials 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000002110 toxicologic effect Effects 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
- G01N33/56988—HIV or HTLV
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
- G01N33/743—Steroid hormones
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- Biotechnology (AREA)
- Virology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Endocrinology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Priority Applications (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IE326690A IE63418B1 (en) | 1990-09-10 | 1990-09-10 | Progression risk of HIV by assay of dehydroepiandrosterone in body fluid |
| ITMI912378A IT1255009B (it) | 1990-09-10 | 1991-09-09 | Metodo per la determinazione del rischio di progressione dell' infezione da hiv e relativo kit diagnostico |
| GB9119256A GB2249833B (en) | 1990-09-10 | 1991-09-09 | Progression risk of HIV by assay of dehydroepiandrosterone in body fluid |
| DE4129932A DE4129932A1 (de) | 1990-09-10 | 1991-09-09 | Screening-verfahren und seine anwendung |
| FR9111118A FR2666657A1 (fr) | 1990-09-10 | 1991-09-09 | Methode pour determiner le risque d'evolution d'une infection provoquee par hiv et sa mise en óoeuvre. |
| JP3307281A JPH04351964A (ja) | 1990-09-10 | 1991-09-09 | スクリーニング方法およびそれの適用方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IE326690A IE63418B1 (en) | 1990-09-10 | 1990-09-10 | Progression risk of HIV by assay of dehydroepiandrosterone in body fluid |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IE63418B1 true IE63418B1 (en) | 1995-04-19 |
Family
ID=11038235
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IE326690A IE63418B1 (en) | 1990-09-10 | 1990-09-10 | Progression risk of HIV by assay of dehydroepiandrosterone in body fluid |
Country Status (6)
| Country | Link |
|---|---|
| JP (1) | JPH04351964A (enrdf_load_stackoverflow) |
| DE (1) | DE4129932A1 (enrdf_load_stackoverflow) |
| FR (1) | FR2666657A1 (enrdf_load_stackoverflow) |
| GB (1) | GB2249833B (enrdf_load_stackoverflow) |
| IE (1) | IE63418B1 (enrdf_load_stackoverflow) |
| IT (1) | IT1255009B (enrdf_load_stackoverflow) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4230684A (en) * | 1978-03-16 | 1980-10-28 | Cornell Research Foundation, Inc. | Method for determining steroids in human body liquids |
| NL194728C (nl) * | 1987-04-16 | 2003-01-07 | Hollis Eden Pharmaceuticals | Farmaceutisch preparaat geschikt voor de profylaxe of therapie van een retrovirale infectie of een complicatie of gevolg daarvan. |
| CA2045686A1 (en) * | 1989-02-01 | 1990-08-02 | Yasir Davash | Hiv p17 assays for monitoring development of aids |
| JPH02213766A (ja) * | 1989-02-15 | 1990-08-24 | Mochida Pharmaceut Co Ltd | 免疫測定用試薬および免疫測定器具 |
-
1990
- 1990-09-10 IE IE326690A patent/IE63418B1/en not_active IP Right Cessation
-
1991
- 1991-09-09 FR FR9111118A patent/FR2666657A1/fr active Granted
- 1991-09-09 JP JP3307281A patent/JPH04351964A/ja active Pending
- 1991-09-09 GB GB9119256A patent/GB2249833B/en not_active Expired - Lifetime
- 1991-09-09 IT ITMI912378A patent/IT1255009B/it active IP Right Grant
- 1991-09-09 DE DE4129932A patent/DE4129932A1/de not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| FR2666657B1 (enrdf_load_stackoverflow) | 1997-02-21 |
| GB2249833B (en) | 1994-09-07 |
| ITMI912378A0 (it) | 1991-09-09 |
| DE4129932A1 (de) | 1992-03-12 |
| GB2249833A (en) | 1992-05-20 |
| GB9119256D0 (en) | 1991-10-23 |
| FR2666657A1 (fr) | 1992-03-13 |
| ITMI912378A1 (it) | 1993-03-09 |
| JPH04351964A (ja) | 1992-12-07 |
| IT1255009B (it) | 1995-10-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6027904A (en) | Platelet count assay using thrombospondin or β-thromboglobulin | |
| JP5744385B2 (ja) | Ｃｖｄ分析 | |
| Yin et al. | The clinical value of assays detecting antibodies against domain I of β2-glycoprotein I in the antiphospholipid syndrome | |
| US20160025738A1 (en) | Prognostic marker to determine the risk for early-onset preeclampsia | |
| Nishihara et al. | Comparison of thyroglobulin and thyroid peroxidase antibodies measured by five different kits in autoimmune thyroid diseases | |
| WO1993003381A1 (en) | Assay for free secretory component and methods for monitoring organ rejection | |
| Lukens et al. | Comparison of different immunoassays for the detection of antibodies against intrinsic factor and parietal cells | |
| Usui et al. | Serum uromodulin is a novel renal function marker in the Japanese population | |
| JP4523587B2 (ja) | Ａ型及びｂ型急性大動脈解離と急性心筋梗塞の鑑別方法及び鑑別用キット | |
| CN112166323A (zh) | 自身抗体的直接免疫测定测量 | |
| JP5952313B2 (ja) | Ｈｉｖ疾病の進行の予後診断法 | |
| JP6901719B2 (ja) | 検査方法及び肝内胆管がん用検査試薬 | |
| KR102228440B1 (ko) | 황산화 다당류를 이용한 면역학적 측정법 | |
| JP3558645B2 (ja) | 甲状腺自己免疫疾患の臨床診断薬としてのポリクローナルヒト抗−ｈＴｇ自己抗体の使用及び患者血清中での抗−ｈＴｇ自己抗体の検出用添加薬 | |
| IE63418B1 (en) | Progression risk of HIV by assay of dehydroepiandrosterone in body fluid | |
| US5108891A (en) | Aids assay | |
| KR920001533B1 (ko) | 인간 폐표면 활성물질의 측정방법 | |
| JP4580869B2 (ja) | 急性大動脈解離の判定方法及び判定用試薬 | |
| JPH0772149A (ja) | 肝癌又は肝硬変の診断薬及び診断法 | |
| EP1596198A1 (en) | Method of measuring oxidized ldl-crp complex and measrurement kit | |
| CN102213722A (zh) | 一种检测蛋白表达水平的试剂盒在制备诊断肝细胞癌的试剂盒中的应用 | |
| CN102597777A (zh) | 诊断血栓形成倾向的方法 | |
| AU2017334408B2 (en) | Point of care assays | |
| JPH11248703A (ja) | 遊離ハプテンの免疫学的測定法 | |
| JPH1164334A (ja) | 尿中トリプシンインヒビターの測定方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Patent lapsed |